Intravascular Lithotripsy for Iliac Disease in TAVR Patients

This study is looking at how well and safely a device called the Shockwave Balloon works for people who need a heart valve replacement (TAVR) but also have severe hardening of the arteries in their pelvis (iliac disease). Normally, this iliac disease would make it hard to do TAVR through the leg, requiring a different approach. The Shockwave Balloon uses sound waves to break up calcium in these arteries. The study wants to see if using this device helps people successfully receive TAVR through the leg. You might be able to join if you are between 18 and 90 years old, have severe iliac disease and severe aortic stenosis, and are planning to have a TAVR procedure.

Study design
This is an observational study involving about 50 participants. It's a single-arm study, meaning everyone receives the same intervention.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study measures success at the time of the Shockwave procedure and again within 30 days of the TAVR procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05862558

Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR

Recruiting
Not specifiedAges 18–90Observational
Baylor Research Institute
~50 participants
Updated 2026-08-21 on ClinicalTrials.gov
What's tested:Shockwave Balloon

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acute technical success per the DISRUPT PAD definition at the time of intervention
Measured over At time of IVL procedure
+1 more outcome measured
Iliac Disease
Aortic Valve Stenosis
1 sites across 1 states
Texas1

Opens a ready-to-send draft in your own email app — review before sending.

  • Acute technical success per the DISRUPT PAD definition at the time of interventionAt time of IVL procedure

    Defined as final residual stenosis ≤30% without flow-limiting dissection (≥ Grade D) of the lesion

  • Success rate of transfemoral delivery of a TAVR system post IVL within 30 days of treatmentAt the time of TAVR procedure

    To know the efficacy of the treatment